Garware Hi-Tech Films Limited — Investor Meet, 14-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance**: Garware Hi-Tech Films reported revenue of INR 466.4 crore for Q3 FY '25, up 2.8% year-over-year from INR 453 crore. For the first nine months, revenue soared 27% to INR 1,561 crore, driven by robust demand across segments. Profit after tax (PAT) for Q3 was INR 60.8 crore, reflecting an 8% increase, while cumulative PAT for the nine-month period reached INR 253.4 crore, up 74% year-on-year. Notably, the company's EBITDA stood at INR 93.7 crore for Q3, a 10.7% increase from INR 84.6 crore in the same quarter last year.

2. **Future Outlook and Growth Drivers**: Management maintains guidance of INR 2,500 crore for FY '26, emphasizing ongoing strength in demand across product lines, including Paint Protection Films (PPF) and Sun Control Films (SCF). An upcoming capex of INR 118 crore for a TPU extrusion line aims to enhance product offerings and operational efficiencies. The introduction of innovative financing options for PPF aims to attract a broader customer base.

3. **Order Book and Operational Updates**: The order book remains strong, with recent growth in the IPD segment, which expanded 24% year-over-year. PPF is set to benefit from the new TPU facility, scheduled for completion in October '26. Management also noted an increase in inquiries for color PPF products, which are expected to capture emerging trends in the automotive sector.

4. **Analyst Q&A Insights (Detailed)**:

- **Revenue and Profitability**: Analysts sought clarity on projected revenues, to which management reaffirmed confidence in meeting growth targets, despite Q3's seasonality.

- **Market Position**: Queries on competitive pressures in the PPF market revealed the company's strong innovation capabilities and product portfolio as key strengths.

- **Operational Challenges**: Management addressed emerging risks, including geopolitical tensions and tariff implications, assuring stakeholders of robust risk management strategies.

- **Capex and Capital Allocation**: Analysts questioned the capex allocation strategy; management assured that internal accruals would fund the expansion projects.

- **Strategic Priorities**: Discussion highlighted a focus on expansion into the healthcare and architectural sectors, emphasizing a commitment to innovation and market penetration.

5. **Market or Regulatory Updates**: Management highlighted potential impacts from U.S. tariff fluctuations but retained a positive outlook on leveraging competitive advantages through backward integration and price positioning.

6. **Strategic Focus Areas**: A clear strategic focus on innovation and product diversification, particularly in high-margin segments like PPF, combined with strong market demand, positions Garware favorably for continued growth.

7. **Investor Insight**: Given the solid financial performance, robust growth outlook, and strategic initiatives in place, the overall health suggests a positive sentiment toward the stock, warranting a 'buy' stance. Investors should remain mindful of potential market challenges and fluctuations in demand during transitional phases.